cefuroxime has been researched along with Sinusitis in 28 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Sinusitis: Inflammation of the NASAL MUCOSA in one or more of the PARANASAL SINUSES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized clinical trial, comparing the efficacy of two oral antibiotics, cefuroxime and co-amoxiclav in the treatment of acute sinusitis, was conducted in 2007." | 9.16 | Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population. ( Alaghehbandan, R; Alinejad, F; Asghari, B; Gholami, A; Lari, AR; Mostafavi, H, 2012) |
| "To compare the efficacy and safety of faropenem medoxomil, 300 mg twice daily for seven or ten days, with cefuroxime axetil 250 mg twice daily for ten days in adults with acute bacterial sinusitis (ABS)." | 9.12 | Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. ( Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J, 2006) |
| "A 10-d course of cefuroxime axetil offered no clinical benefit to children with an acute respiratory illness and imaging evidence of acute sinusitis." | 9.11 | Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. ( Alho, OP; Ilkko, E; Koivunen, P; Kristo, A; Luotonen, J; Uhari, M, 2005) |
| "We started therapy sinusitis of our patients with antibiotics cefuroxime axetil (Zinnat, GSK), clarithromycin (Klacid Uno, Abbott) and orally given steroid-prednisone in one group (A+S) 56 patients." | 9.11 | [Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)]. ( Klatka, J; Obszańska, B; Polberg, K; Remer, M, 2005) |
| "To observe the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis in adults." | 9.09 | [Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis]. ( Li, XP; Qin, ZM; Tan, QL; Yin, AF; Zheng, RH; Zhou, YY; Zhu, L, 2000) |
| "The aim of this multicentre, randomized study was to compare the efficacy and safety of moxifloxacin (BAY 12-8039), a new 8-methoxy fluoroquinolone, with that of cefuroxime axetil for the treatment of acute bacterial sinusitis in adults." | 9.09 | A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. ( Bagger-Sjöbäck, D; Gehanno, P; Hampel, B; Ibanez, JM; Nikolaidis, P; Siegert, R; Sommerauer, B, 2000) |
| "The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 9.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
| "In a double-blind, multicentre trial, 382 patients with a diagnosis of acute purulent sinusitis were randomised to receive sparfloxacin 200 mg once daily for 5 days following a loading dose of 400 mg on day 1 (n = 193) or cefuroxime axetil 250 mg twice daily for 8 days (n = 189)." | 9.08 | Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group. ( Berche, P; Gehanno, P, 1996) |
| "A study of the efficacy of cefuroxime axetil was conducted for the treatment of acute sinusitis in childhood." | 9.08 | Cefuroxime axetil in the treatment of acute sinusitis in childhood. ( Gürses, N; Islek, I; Kalayci, AG; Uysal, S, 1996) |
| "We conducted a prospective, randomized, double-blind pilot study of oral ciprofloxacin (500 mg twice daily) versus cefuroxime axetil (250 mg twice daily) for 2 to 3 weeks in the treatment of adult patients with a clinical diagnosis of acute bacterial maxillary sinus infections or acute exacerbation of chronic bacterial sinusitis." | 9.08 | Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. ( Echols, RM; Heyd, A; Klein, GL; Whalen, E, 1998) |
| "Cefuroxime axetil is a beta-lactamase-stable, second-generation, oral cephalosporin that penetrates sinus tissue in concentrations exceeding the MIC90 values (the minimum concentration of drug needed to inhibit the growth of 90% of an isolate of a particular microorganism) for pathogens most commonly associated with acute sinusitis, including Streptococcus pneumoniae and Haemophilus influenzae." | 8.79 | Cefuroxime axetil in the treatment of sinusitis. A review. ( Collins, JJ; Graham, JA; Pakes, GE; Rauch, AM, 1994) |
| "A method for quantitative determination of cefuroxime in mixed saliva of patients with sinusitis by using spectrophotometer Shimadzu UV-1800, combined with the IBM PC is described." | 7.80 | [Study on pharmacokinetics of cefuroxime by dynamics of its distribution in oral fluid of patients with sinusitis]. ( Kulapina, OI; Mikhailova, MS, 2014) |
| "The aim of the study was to substantiate clinically and microbiologically administration of such oral cephalosporins as cefuroxime axetil and ceftibuten in acute sinusitis." | 7.71 | [Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis]. ( Kamanin, EI; Kozlov, SN; Otvagin, IV; Strachunskiĭ, LS, 2001) |
| "Twenty-four atopic children with allergic rhinitis, asthma and maxillary sinusitis were treated with a combination of cefuroxime 50-80 mg/kg/day and N-acetyl-cysteine 15-25 mg/kg/day administered intramuscularly for 10 days." | 7.67 | A combination of cefuroxime and N-acetyl-cysteine for the treatment of maxillary sinusitis in children with respiratory allergy. ( Andreoli, A; Baronio, L; Boner, AL; Valletta, EA; Vallone, G, 1984) |
| "A randomized clinical trial, comparing the efficacy of two oral antibiotics, cefuroxime and co-amoxiclav in the treatment of acute sinusitis, was conducted in 2007." | 5.16 | Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population. ( Alaghehbandan, R; Alinejad, F; Asghari, B; Gholami, A; Lari, AR; Mostafavi, H, 2012) |
| "To compare the efficacy and safety of faropenem medoxomil, 300 mg twice daily for seven or ten days, with cefuroxime axetil 250 mg twice daily for ten days in adults with acute bacterial sinusitis (ABS)." | 5.12 | Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. ( Echols, R; Kowalsky, S; Rosemore, M; Tosiello, R; Upchurch, J, 2006) |
| "A 10-d course of cefuroxime axetil offered no clinical benefit to children with an acute respiratory illness and imaging evidence of acute sinusitis." | 5.11 | Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial. ( Alho, OP; Ilkko, E; Koivunen, P; Kristo, A; Luotonen, J; Uhari, M, 2005) |
| "We started therapy sinusitis of our patients with antibiotics cefuroxime axetil (Zinnat, GSK), clarithromycin (Klacid Uno, Abbott) and orally given steroid-prednisone in one group (A+S) 56 patients." | 5.11 | [Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)]. ( Klatka, J; Obszańska, B; Polberg, K; Remer, M, 2005) |
| "To observe the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis in adults." | 5.09 | [Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis]. ( Li, XP; Qin, ZM; Tan, QL; Yin, AF; Zheng, RH; Zhou, YY; Zhu, L, 2000) |
| "A randomized, open, multiple-dose, pharmacological study, employing cefuroxime axetil, an approved oral antimicrobial for the treatment of acute bacterial rhinosinusitis, was developed." | 5.09 | Penetration of cefuroxime into chronically inflamed sinus mucosa. ( Dinis, PB; Gomes, A; Lobato, R; Martins, ML; Monteiro, MC, 1999) |
| "The aim of this multicentre, randomized study was to compare the efficacy and safety of moxifloxacin (BAY 12-8039), a new 8-methoxy fluoroquinolone, with that of cefuroxime axetil for the treatment of acute bacterial sinusitis in adults." | 5.09 | A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group. ( Bagger-Sjöbäck, D; Gehanno, P; Hampel, B; Ibanez, JM; Nikolaidis, P; Siegert, R; Sommerauer, B, 2000) |
| "The addition of fluticasone to xylometazoline and antimicrobial therapy with cefuroxime improves clinical success rates and accelerates recovery of patients with a history of chronic rhinitis or recurrent sinusitis who present for treatment of acute rhinosinusitis." | 5.09 | Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial. ( Califf, RM; Dolor, RJ; Hellkamp, AS; Simel, DL; Williams, JW; Witsell, DL, 2001) |
| "In a double-blind, multicentre trial, 382 patients with a diagnosis of acute purulent sinusitis were randomised to receive sparfloxacin 200 mg once daily for 5 days following a loading dose of 400 mg on day 1 (n = 193) or cefuroxime axetil 250 mg twice daily for 8 days (n = 189)." | 5.08 | Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group. ( Berche, P; Gehanno, P, 1996) |
| "A study of the efficacy of cefuroxime axetil was conducted for the treatment of acute sinusitis in childhood." | 5.08 | Cefuroxime axetil in the treatment of acute sinusitis in childhood. ( Gürses, N; Islek, I; Kalayci, AG; Uysal, S, 1996) |
| "We conducted a prospective, randomized, double-blind pilot study of oral ciprofloxacin (500 mg twice daily) versus cefuroxime axetil (250 mg twice daily) for 2 to 3 weeks in the treatment of adult patients with a clinical diagnosis of acute bacterial maxillary sinus infections or acute exacerbation of chronic bacterial sinusitis." | 5.08 | Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis. ( Echols, RM; Heyd, A; Klein, GL; Whalen, E, 1998) |
| " As an example, a study comparing 5 days of cefuroxime axetil therapy with either 10 days of cefuroxime axetil or amoxycillin/clavulanate showed no differences in rates of clinical cure, bacteriological eradication and recurrence in paediatric patients with either acute otitis media or sinusitis." | 4.80 | Short courses of antibiotic in acute otitis media and sinusitis infections. ( Pichicero, M, 2000) |
| "Cefuroxime axetil is a beta-lactamase-stable, second-generation, oral cephalosporin that penetrates sinus tissue in concentrations exceeding the MIC90 values (the minimum concentration of drug needed to inhibit the growth of 90% of an isolate of a particular microorganism) for pathogens most commonly associated with acute sinusitis, including Streptococcus pneumoniae and Haemophilus influenzae." | 4.79 | Cefuroxime axetil in the treatment of sinusitis. A review. ( Collins, JJ; Graham, JA; Pakes, GE; Rauch, AM, 1994) |
| "A method for quantitative determination of cefuroxime in mixed saliva of patients with sinusitis by using spectrophotometer Shimadzu UV-1800, combined with the IBM PC is described." | 3.80 | [Study on pharmacokinetics of cefuroxime by dynamics of its distribution in oral fluid of patients with sinusitis]. ( Kulapina, OI; Mikhailova, MS, 2014) |
| "The aim of the study was to substantiate clinically and microbiologically administration of such oral cephalosporins as cefuroxime axetil and ceftibuten in acute sinusitis." | 3.71 | [Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis]. ( Kamanin, EI; Kozlov, SN; Otvagin, IV; Strachunskiĭ, LS, 2001) |
| "Twenty-four atopic children with allergic rhinitis, asthma and maxillary sinusitis were treated with a combination of cefuroxime 50-80 mg/kg/day and N-acetyl-cysteine 15-25 mg/kg/day administered intramuscularly for 10 days." | 3.67 | A combination of cefuroxime and N-acetyl-cysteine for the treatment of maxillary sinusitis in children with respiratory allergy. ( Andreoli, A; Baronio, L; Boner, AL; Valletta, EA; Vallone, G, 1984) |
| "All sultamicillin-treated and all but three cefuroxime axetil-treated patients experienced cure or improvement; only one cefuroxime axetil-treated patient discontinued treatment due to treatment failure." | 2.67 | An open multicentre study to compare the efficacy and safety of sultamicillin with that of cefuroxime axetil in acute ear nose and throat infections in adults. ( Alvart, R, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 11 (39.29) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 4 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kulapina, OI | 1 |
| Mikhailova, MS | 1 |
| Parvizi, N | 1 |
| Choudhury, N | 1 |
| Singh, A | 1 |
| Kromberg, R | 1 |
| Mozet, C | 1 |
| Fritzsch, D | 1 |
| Dawczynski, J | 1 |
| Dietz, A | 1 |
| Lari, AR | 1 |
| Alinejad, F | 1 |
| Alaghehbandan, R | 1 |
| Mostafavi, H | 1 |
| Asghari, B | 1 |
| Gholami, A | 1 |
| Namyslowski, G | 1 |
| Misiolek, M | 1 |
| Czecior, E | 1 |
| Malafiej, E | 1 |
| Orecka, B | 1 |
| Namyslowski, P | 1 |
| Misiolek, H | 1 |
| Li, XP | 1 |
| Qin, ZM | 1 |
| Zheng, RH | 1 |
| Tan, QL | 1 |
| Zhou, YY | 1 |
| Zhu, L | 1 |
| Yin, AF | 1 |
| Namysłowski, W | 1 |
| Namysłowski, G | 1 |
| Buszman, E | 1 |
| Misiołek, M | 1 |
| Kristo, A | 1 |
| Uhari, M | 1 |
| Luotonen, J | 1 |
| Ilkko, E | 1 |
| Koivunen, P | 1 |
| Alho, OP | 1 |
| Lund, VJ | 2 |
| Whittet, H | 1 |
| Remer, M | 1 |
| Polberg, K | 1 |
| Obszańska, B | 1 |
| Klatka, J | 1 |
| Upchurch, J | 1 |
| Rosemore, M | 1 |
| Tosiello, R | 1 |
| Kowalsky, S | 1 |
| Echols, R | 1 |
| Boner, AL | 1 |
| Valletta, EA | 1 |
| Andreoli, A | 1 |
| Vallone, G | 1 |
| Baronio, L | 1 |
| Friedman, WH | 1 |
| Katsantonis, GP | 1 |
| Bumpous, JM | 1 |
| Pakes, GE | 1 |
| Graham, JA | 1 |
| Rauch, AM | 1 |
| Collins, JJ | 1 |
| Gehanno, P | 2 |
| Berche, P | 1 |
| Gürses, N | 1 |
| Kalayci, AG | 1 |
| Islek, I | 1 |
| Uysal, S | 1 |
| Katsinelos, P | 1 |
| Katsos, J | 1 |
| Xiarchos, P | 1 |
| Goulis, J | 1 |
| Celik, A | 1 |
| Klein, GL | 1 |
| Whalen, E | 1 |
| Echols, RM | 1 |
| Heyd, A | 1 |
| Kessler, A | 1 |
| Berenholz, LP | 1 |
| Segal, S | 1 |
| Dinis, PB | 1 |
| Monteiro, MC | 1 |
| Lobato, R | 1 |
| Martins, ML | 1 |
| Gomes, A | 1 |
| Siegert, R | 1 |
| Nikolaidis, P | 1 |
| Bagger-Sjöbäck, D | 1 |
| Ibanez, JM | 1 |
| Hampel, B | 1 |
| Sommerauer, B | 1 |
| Ogle, JW | 1 |
| Pichicero, M | 1 |
| Otvagin, IV | 1 |
| Kamanin, EI | 1 |
| Strachunskiĭ, LS | 1 |
| Kozlov, SN | 1 |
| Dolor, RJ | 1 |
| Witsell, DL | 1 |
| Hellkamp, AS | 1 |
| Williams, JW | 1 |
| Califf, RM | 1 |
| Simel, DL | 1 |
| Winn, RJ | 1 |
| Alvart, R | 1 |
| Sudderick, RM | 1 |
| Thomson, JP | 1 |
| McCombe, A | 1 |
| Mackay, IS | 1 |
2 reviews available for cefuroxime and Sinusitis
| Article | Year |
|---|---|
Cefuroxime axetil in the treatment of sinusitis. A review.
Topics: Acute Disease; Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; Chronic Disease; Clinical Tr | 1994 |
Short courses of antibiotic in acute otitis media and sinusitis infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefuroxime; Clavulanic Acid; Drug Administration | 2000 |
14 trials available for cefuroxime and Sinusitis
| Article | Year |
|---|---|
Comparison of cefuroxime and co-amoxiclav in the treatment of acute sinusitis in a sample of the Iranian population.
Topics: Acute Disease; Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agen | 2012 |
Comparison of the efficacy and tolerability of amoxycillin/clavulanic acid 875 mg b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults.
Topics: Administration, Oral; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; C | 2002 |
[Comparison of the effectiveness of levofloxacin and cefuroxime for the treatment of sinusitis].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefuroxime; Drug Administrati | 2000 |
[Evaluation of microorganisms ability to beta-lactamase production in exacerbation of chronic sinusitis treated with beta-lactam antibiotics].
Topics: beta-Lactamases; beta-Lactams; Cefuroxime; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; H | 2003 |
Cefuroxime axetil versus placebo for children with acute respiratory infection and imaging evidence of sinusitis: a randomized, controlled trial.
Topics: Acute Disease; Anti-Bacterial Agents; Cefuroxime; Child; Child, Preschool; Double-Blind Method; Fema | 2005 |
[Chronic sinusitis therapy with antibiotics (axetyl cefuroxym, clarithromycin) and steroid (prednisone)].
Topics: Anti-Infective Agents; Cefuroxime; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Femal | 2005 |
Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infectio | 2006 |
Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
Topics: Acute Disease; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Double-Blind Method; Female | 1996 |
Cefuroxime axetil in the treatment of acute sinusitis in childhood.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefuroxime; Cephal | 1996 |
Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Analysis of Variance; Anti-Infective Agents; Cefuroxime; Cephalosporins; | 1998 |
Penetration of cefuroxime into chronically inflamed sinus mucosa.
Topics: Adult; Aged; Cefuroxime; Cephalosporins; Chronic Disease; Female; Humans; Male; Microbial Sensitivit | 1999 |
A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
Topics: Acute Disease; Adult; Anti-Infective Agents; Aza Compounds; Bacterial Infections; Cefuroxime; Cephal | 2000 |
Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The CAFFS Trial: a randomized controlled trial.
Topics: Acute Disease; Administration, Intranasal; Adult; Androstadienes; Anti-Inflammatory Agents; Cefuroxi | 2001 |
An open multicentre study to compare the efficacy and safety of sultamicillin with that of cefuroxime axetil in acute ear nose and throat infections in adults.
Topics: Adult; Ampicillin; Bacterial Infections; Cefuroxime; Drug Therapy, Combination; Humans; Otitis Media | 1992 |
12 other studies available for cefuroxime and Sinusitis
| Article | Year |
|---|---|
[Study on pharmacokinetics of cefuroxime by dynamics of its distribution in oral fluid of patients with sinusitis].
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Cefuroxime; Female; Humans; Male; Saliva; Sensitiv | 2014 |
Complicated periorbital cellulitis: case report and literature review.
Topics: Abscess; Adolescent; Anti-Infective Agents; Cefuroxime; Contrast Media; Decompression, Surgical; Dra | 2012 |
[A rare complication of acute sinusitis].
Topics: Aged; Cavernous Sinus Thrombosis; Cefuroxime; Combined Modality Therapy; Decompression, Surgical; Di | 2012 |
Cefuroxime axetil: management of adult sinusitis in the clinic.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefuroxime; | 1989 |
A combination of cefuroxime and N-acetyl-cysteine for the treatment of maxillary sinusitis in children with respiratory allergy.
Topics: Acetylcysteine; Adolescent; Asthma; Cefuroxime; Cephalosporins; Child; Chronic Disease; Drug Therapy | 1984 |
Staging of chronic hyperplastic rhinosinusitis: treatment strategies.
Topics: Beclomethasone; Cefuroxime; Chronic Disease; Clinical Protocols; Combined Modality Therapy; Ethmoid | 1995 |
Acute haemorrhagic colitis related to cefuroxime.
Topics: Adult; Cefuroxime; Cephalosporins; Colitis; Colonoscopy; Gastrointestinal Hemorrhage; Humans; Male; | 1996 |
Transnasal endoscopic drainage of a medial subperiosteal orbital abscess.
Topics: Abscess; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefuroxim | 1998 |
Antimicrobial therapy for ambulatory pediatrics.
Topics: Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefuroxime; Cephalexin; Cep | 1999 |
[Comparative clinical efficacy and tolerance of cefuroxime axetil (zinnat) and ceftibuten (cedex) in patients with acute sinusitis].
Topics: Acute Disease; Adult; Ceftibuten; Cefuroxime; Cephalosporins; Drug Tolerance; Female; Humans; Male; | 2001 |
Do intranasal corticosteroids aid treatment of acute sinusitis in patients with a history of recurrent sinus symptoms?
Topics: Acute Disease; Administration, Intranasal; Adult; Androstadienes; Anti-Inflammatory Agents; Cefuroxi | 2002 |
An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
Topics: Administration, Oral; Bacterial Infections; Cefuroxime; Drug Evaluation; Female; Humans; Male; Middl | 1992 |